Chengzhi Co., Ltd. (SHE:000990)
China · Delayed Price · Currency is CNY 5.40
-0.22 (-3.91%)
Oct 23, 2026, 3:04 PM CST
Chengzhi Market Cap
Chengzhi has a market cap or net worth of 9.19 billion as of October 22, 2026. It is the 8,557th most valuable company in the world and the 1,733rd biggest in China. Its market cap has increased by 1.89% in one year.
Market Cap
9.19B
Enterprise Value
12.74B
Revenue
10.74B
Global Rank
Country Rank
#1,733 China
PE Ratio
102.31
ChartMarket Cap Chart
Since January 2, 2001, Chengzhi's market cap has increased from 4.51B to 9.19B, an increase of 103.87%. That is a compound annual growth rate of 2.80%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 9.19B | -4.55% |
| Dec 31, 2025 | 9.62B | 2.19% |
| Dec 31, 2024 | 9.42B | -5.60% |
| Dec 29, 2023 | 9.98B | -6.70% |
| Dec 30, 2022 | 10.69B | -44.37% |
| Dec 31, 2021 | 19.23B | 33.39% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Shanghai Medicilon | 11.03B |
| Chengdu Olymvax Biopharmaceuticals | 10.96B |
| Tibet Cheezheng Tibetan Medicine | 10.91B |
| Inner Mongolia Furui Medical Science | 10.48B |
| Mabwell (Shanghai) Bioscience | 9.85B |
| Staidson (Beijing) BioPharmaceuticals | 9.84B |
| Pacific Shuanglin Bio-pharmacy | 9.12B |
| Novoprotein Scientific | 9.06B |